Acquisition of Biovire - Summary of Preliminary Purchase Price Allocation (Details) - USD ($) $ in Thousands |
Jun. 30, 2026 |
Dec. 31, 2025 |
Jul. 20, 2025 |
|---|---|---|---|
| Liabilities assumed | |||
| Deferred tax liability | $ 307 | $ 307 | |
| Goodwill | $ 10,297 | $ 10,297 | $ 10,300 |
| Biovire | |||
| Identifiable assets acquired | |||
| Cash | 4,033 | ||
| Current assets | 2,565 | ||
| Operating lease right-of-use assets | 3,413 | ||
| Property and equipment, net | 16,610 | ||
| Intangible assets | 600 | ||
| Total identifiable assets acquired | 27,221 | ||
| Liabilities assumed | |||
| Current liabilities | 2,410 | ||
| Operating lease liabilities, non-current portion | 2,800 | ||
| Long-term debt | 3,000 | ||
| Deferred tax liability | 307 | ||
| Other long-term liabilities | 2,157 | ||
| Total liabilities assumed | 10,674 | ||
| Net identifiable assets acquired | 16,547 | ||
| Goodwill | 10,297 | ||
| Total fair value of consideration paid | $ 26,844 |
| X | ||||||||||
- Definition Business combination recognized asset acquired operating lease right-of-use assets. No definition available.
|
| X | ||||||||||
- Definition Business combination recognized identifiable assets acquired and liabilities assumed operating lease liabilities non current portion. No definition available.
|
| X | ||||||||||
- Definition Amount of asset acquired in business combination and recognized at acquisition date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of cash and cash equivalent acquired in business combination and recognized at acquisition date. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of asset acquired in business combination and recognized at acquisition date, classified as current. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of liability assumed in business combination and recognized at acquisition date, classified as current. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of deferred tax liability assumed in business combination and recognized at acquisition date. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of identifiable intangible asset acquired in business combination and recognized at acquisition date. Excludes goodwill and financial asset. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of liability assumed in business combination and recognized at acquisition date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of asset acquired in excess of (less than) liability assumed in business combination and recognized at acquisition date. Excludes goodwill. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of long-term debt assumed in business combination and recognized at acquisition date, classified as noncurrent. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of liability assumed in business combination and recognized at acquisition date, classified as other and noncurrent. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of property, plant, and equipment acquired in business combination and recognized at acquisition date. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of asset acquired in excess of (less than) liability assumed plus goodwill in business combination and recognized at acquisition date. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|